RecruitingNCT04330963

International Swiss Primary Hypersomnolence and Narcolepsy Cohort Study

Studying Idiopathic hypersomnia

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Insel Gruppe AG, University Hospital Bern
Principal Investigator
Claudio L Bassetti, Prof.
Insel Gruppe
Enrollment
600 enrolled
Eligibility
10-70 years · All sexes
Timeline
2020 – 2026

Study locations (1)

Collaborators

Klinik Barmelweid · Zentrum für Schlafmedizin Basel · Ospedale Regionale di Lugano · Cantonal Hospital of St. Gallen · Zurzach Care Klinik für Schlafmedizin · University Children's Hospital, Zurich · University Children's Hospital Basel · Centre Lausannios de Sommeil · Private Universität Witten-Herdecke and Orfea Fachklinik für Schlafmedizin, Witten, Germany · Leiden University Medical Center, Leiden, Netherlands · University of Bologna, Bologna, Italy

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04330963 on ClinicalTrials.gov

Other trials for Idiopathic hypersomnia

Additional recruiting or active studies for the same condition.

See all trials for Idiopathic hypersomnia →

← Back to all trials